The role of FOSL1 in stem-like cell reprogramming processes
Open Access
- 19 July 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-11
Abstract
Cancer stem-like cells (CSCs) have self-renewal abilities responsible for cancer progression, therapy resistance, and metastatic growth. The glioblastoma stem-like cells are the most studied among CSC populations. A recent study identified four transcription factors (SOX2, SALL2, OLIG2, and POU3F2) as the minimal core sufficient to reprogram differentiated glioblastoma (GBM) cells into stem-like cells. Transcriptomic data of GBM tissues and cell lines from two different datasets were then analyzed by the SWItch Miner (SWIM), a network-based software, and FOSL1 was identified as a putative regulator of the previously identified minimal core. Herein, we selected NTERA-2 and HEK293T cells to perform an in vitro study to investigate the role of FOSL1 in the reprogramming mechanisms. We transfected the two cell lines with a constitutive FOSL1 cDNA plasmid. We demonstrated that FOSL1 directly regulates the four transcription factors binding their promoter regions, is involved in the deregulation of several stemness markers, and reduces the cells’ ability to generate aggregates increasing the extracellular matrix component FN1. Although further experiments are necessary, our data suggest that FOSL1 reprograms the stemness by regulating the core of the four transcription factors.Keywords
Funding Information
- Progetti di Ricerca Medi 2018: Network medicine-based machine learning and graph theory algorithms for precision oncology
This publication has 40 references indexed in Scilit:
- Extracellular Matrix Remodeling: The Common Denominator in Connective Tissue Diseases Possibilities for Evaluation and Current Understanding of the Matrix as More Than a Passive Architecture, but a Key Player in Tissue FailureASSAY and Drug Development Technologies, 2013
- A restricted cell population propagates glioblastoma growth after chemotherapyNature, 2012
- CAMTA1 is a novel tumour suppressor regulated by miR‐9/9* in glioblastoma stem cellsThe EMBO Journal, 2011
- TGF-β Receptor Inhibitors Target the CD44high/Id1high Glioma-Initiating Cell Population in Human GlioblastomaCancer Cell, 2010
- Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cellsMolecular Cancer, 2010
- Integrin Alpha 6 Regulates Glioblastoma Stem CellsCell Stem Cell, 2010
- Epstein-Barr virus-encoded EBNA1 inhibits the canonical NF-κB pathway in carcinoma cells by inhibiting IKK phosphorylationMolecular Cancer, 2010
- SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human GlioblastomaCell Stem Cell, 2009
- Prospective identification of tumorigenic breast cancer cellsProceedings of the National Academy of Sciences of the United States of America, 2003
- Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cellNature Medicine, 1997